FGF2 and myocardial infarction: Additionally, cardiac‐specific overexpression of human FGF2 results in decreased postischemic cardiac dysfunction and myocardial infarction, whereas ablation of the Fgf2 gene results in worsened postischemic outcomes in an ex vivo work‐performing murine model of global IR injury (House et al. 2003).